Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study-Reference-Cited by-同舟云学术

Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study

Published:2021-08-28 Issue: Volume: Page:
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Goldhaber Samuel Z.^ORCID,Ageno Walter,Casella Ivan B.,Chee Kok Han,Schellong Sebastian,Singer Daniel E.,Voccia Isabelle,Tang Wenbo,Schulman Sam

Funder

Boehringer Ingelheim

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-021-02463-x.pdf

Reference26 articles.

1. Kearon C et al (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149(2):315–352

2. Ageno W et al (2017) RE-COVERY DVT/PE: rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate. Thromb Haemost 117(2):415–421

3. Beyer-Westendorf J, Ageno W (2015) Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism. Thromb Haemost 113(2):231–246

4. Pradaxa® USA FDA Prescribing Information. July 2020. https://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf. Accessed 20 March 2021.

5. Goldhaber SZ et al (2020) Profile of patients diagnosed with acute venous thromboembolism in routine clinical practice: the RE-COVERY DVT/PE study. Am J Med 133(8):936–945

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of dabigatran;Glavvrač (Chief Medical Officer);2024-01-22

2. Clinical profile and outcome of isolated pulmonary embolism: a systematic review and meta-analysis;eClinicalMedicine;2023-05

3. Pharmacokinetics, safety, and bioequivalence of apixaban tablets in healthy Chinese subjects under fasting and fed conditions;Int. Journal of Clinical Pharmacology and Therapeutics;2023-03-01

4. Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review;Advances in Therapy;2022-10-16